Robert Benjamin Stein, Director of Protagenic Therapeutics, Inc.\new PTIX, has filed 0 purchases and 7 sales on the open market. The latest trade was on 24/03/25.

RS

RS

Robert Benjamin Stein

Director

Company

Protagenic Therapeutics, Inc.\new PTIX

First filing

23/03/15

Trades

9 trades

Buys / sales

0 / 7

12-month net buying

No record

Last trade

24/03/25

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Mimedx GroupMDXG	Open-market sale	23/05/15–23/05/16	23/05/17	13,972 sh2 trades	$6.00avg.	$83,854.8	−4.2%
Mimedx GroupMDXG	Open-market sale	23/05/10	23/05/12	5,869 sh	$5.93	$34,803.17	−1.7%
Mimedx GroupMDXG	Open-market sale	23/05/04	23/05/09	51,756 sh	$5.34	$276,377.04	−13.3%
Mimedx GroupMDXG	Open-market sale	23/04/25	23/04/27	5,987 sh	$3.74	$22,391.38	−1.5%
Mimedx GroupMDXG	Open-market sale	23/04/11	23/04/13	5,996 sh	$3.31	$19,846.76	−1.5%
Mimedx GroupMDXG	Open-market sale	23/03/07	23/03/09	12,355 sh	$4.24	$52,385.2	−4.4%